ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 756170 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 756170; 2) Community: the network communities that were significantly associated with the response to NSC 756170; 3) Molecule: the relationships between components within communities and NSC 756170; 4) MDR: the compounds that were significantly associated with the NSC 756170.

NSC Compound Enrichment Correlation
NSC 212509 Ergosta-2,24-dien-26-oic acid, 5,6-epoxy-4,14,17,20,22-pentahydroxy-1-oxo-, .delta.-lactone, (4.beta.,5.beta.,6.beta.,17.alpha.,22R)- (9CI) 0.0382675857669585 0.16049512
NSC 281245 COMPACTIN 0.0382675857669585 0.14778866
NSC 286122 Null 0.0382675857669585 0.13737524
NSC 300288 1H-Benz[de]isoquinoline-1,3(2H)-dione, 2-[2-(dimethylamino)ethyl]-5-nitro- 0.0382675857669585 0.22379927
NSC 302289 BOHLMANN K2631 0.0382675857669585 0.11503249
NSC 302325 2,4-Pyrimidinediamine, 5-(4-chloro-3-nitrophenyl)-6-ethyl- 0.0382675857669585 0.46239147
NSC 3053 Actinomycin D 0.0382675857669585 0.18670298
NSC 328403 Acetamide, N-(4-formyl-5,6,7,9-tetrahydro-1,2,3,10- tetramethoxy-9-oxobenzo[a]heptalen-7-yl)-, (S)- 0.0382675857669585 0.57824435
NSC 617965 Null 0.0382675857669585 0.18879581
NSC 620077 Null 0.0382675857669585 0.30589802
Total:100  Current:83    [First] [Prev] [Next] [Last]